,i  #aag? ,,congress  #a/ ,session  ,h4 
,r4 #cfid  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,june #d1 #bjba,mr4   
,c>t] ( ,georgia introduc$ ! foll[+     
bill2 :i* 0 ref]r$ to ! ,committee on   
,ways & ,means  ,a ,,bill  ,to direct ! 
,secret>y ( ,heal? & ,human ,s]vices1 9 
consultation ) ! ,unit$ ,/ates ,trade   
,repres5tative & o!r heads ( ,f$]al     
ag5cies1 to submit to ,congress a report
 on ! impact ( a waiv] ( c]ta9          
obligations ( memb] nations "u !        
,agreem5t on ,trade-,relat$ ,aspects (  
,intellectual ,prop]ty ,rights on global
 ,,covid-#ai vacc9e access1 & = o!r     
purposes4  #a4 ,int]ag5cy public heal?  
report on impact ( ,,trips waiv] on     
global ,,covid-#ai vacc9e access  7a7   
,report & conclusion ,n lat] ?an #fj    
days aft] ! date ( ! enactm5t ( ?is     
section1 ! ,secret>y ( ,heal? & ,human  
,s]vices1 9 consultation ) ! ,unit$     
,/ates ,trade ,repres5tative1 !         
,secret>y ( ,comm]ce1 ! ,commission] (  
,food & ,drugs1 & ! ,director ( ! ,c5t]s

 = ,disease ,control & ,prev5tion1 %all 
submit to ,congress1 & make publicly    
available on a public website ( !       
,dep>tm5t ( ,heal? & ,human ,s]vices1 a 
report conta9+ ! foll[+3 7#a7 ,an       
assessm5t ( h[ ! elim9ation or waiv]    
describ$ 9 subsection 7b7 w\ld impact   
ea* ( ! foll[+ dur+ ! cov]$ p]iod3 7,a7 
,access to ,,covid-#ai vacc9es 9 !      
,unit$ ,/ates4  7,b7 ,access to         
,,covid-#ai vacc9es globally4  7,c7     
,global ,,covid-#ai vacc9e manufactur+  
capacity4  7,d7 ,global supply *a9s (   
,,covid-#ai vacc9es & relat$ te*nologies
 & ! inputs ne$$ to produce ^? vacc9es &
 relat$ te*nologies4  7,e7 ,exports &   
imports by ! ,unit$ ,/ates ( ,,covid-#ai
 vacc9es & relat$ te*nologies & ! inputs
 ne$$ to produce su* vacc9es & relat$   
te*nologies4  7,f7 ,bioph>maceutical    
product manufactur+ 9 ! ,unit$ ,/ates & 
! inputs ne$$ to produce                
bioph>maceutical products4  7,g7        
,inve/m5t 9 bioph>maceutical production 
9 ! ,unit$ ,/ates & 9 rese>* &          

developm5t 9 bioph>maceutical products  
to respond to future infecti\s disease  
outbreaks & p&emics4  7#b7 ,!           
,secret>y's conclusion on :e!r an       
elim9ation or waiv]1 z describ$ 9       
subsection 7b71 dur+ ! cov]$ p]iod--    
7,a7 w mat]ially increase global        
,,covid-#ai vacc9e access2 or  7,b7 w h 
a negative impact on any ( ! factors    
describ$ 9 subp>agraphs 7,a7 ?r\gh 7,g7 
( p>agraph 7#a74  7b7 ,,u/r ,opposition 
,! ,unit$ ,/ates ,trade ,repres5tative  
%all oppose an elim9ation or waiv] ( an 
obligation impos$ on memb]s ( ! ,_w     
,trade ,organization "u ! ,agreem5t on  
,trade-,relat$ ,aspects ( ,intellectual 
,prop]ty ,rights ) respect to vacc9es   
int5d$ to prev5t or mitigate            
,,covid-#ai1 if ! ,secret>y concludes "u
 subsection 7a77#b7 t su* elim9ation or 
waiv]-- 7#a7 w n mat]ially increase     
global ,,covid-#ai vacc9e access2 or    
7#b7 w h a negative impact on any ( !   
factors describ$ 9 subp>agraphs 7,a7    
?r\gh 7,g7 ( subsection 7a77#a74  7c7   

,cov]$ p]iod def9$ ,! t]m cov]$ p]iod   
means ! p]iod beg9n+ on ! date ( !      
enactm5t ( ?is section & end+ on        
,decemb] #ca1 #bjbb4